ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 143925 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 143925; 2) Community: the network communities that were significantly associated with the response to NSC 143925; 3) Molecule: the relationships between components within communities and NSC 143925; 4) MDR: the compounds that were significantly associated with the NSC 143925.

NSC Compound Enrichment Correlation
NSC 648365 Insulin-Methotrexate conjugate 0.00888636978630782 0.26758671
NSC 657676 Null 0.00888636978630782 0.021205243
NSC 658274 Naphtho[2,3-d]thiazole-4,9-dione, 2-[(2,5-dichlorophenyl) amino]- 0.00888636978630782 0.22124696
NSC 757948 (1R,2E,6R,10E,11aS,13S,14aR)-1,13-dihydroxy-6-(2-methoxyethyl)-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.00888636978630782 -0.23303338
NSC 116789 Acovenoside B 0.0102077332082016 0.75490699
NSC 179207 Benzo[c]phenanthridinium, 2,3,8,9-tetramethoxy-5-methyl-, fluorosulfate, hemihydrate 0.0102077332082017 0.11183457
NSC 615804 ANTINEOPLASTIC-615804 0.0102077332082017 0.078061647
NSC 664313 Null 0.0102077332082017 0.083970188
NSC 665496 Null 0.0102077332082017 0.067514439
NSC 676772 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-L-arbinopyranosyl] ester 0.0102077332082017 -0.26973786
Total:53  Current:9    [First] [Prev] [Next] [Last]